Open Access

Enhanced transmission of malaria parasites to mosquitoes in a murine model of type 2 diabetes

Malaria Journal201615:231

https://doi.org/10.1186/s12936-016-1277-7

Received: 21 November 2015

Accepted: 12 April 2016

Published: 21 April 2016

Abstract

Background

More than half of the world’s population is at risk of malaria and simultaneously, many malaria-endemic regions are facing dramatic increases in the prevalence of type 2 diabetes. Studies in murine malaria models have examined the impact of malaria infection on type 2 diabetes pathology, it remains unclear how this chronic metabolic disorder impacts the transmission of malaria. In this report, the ability type 2 diabetic rodents infected with malaria to transmit parasites to Anopheles stephensi mosquitoes is quantified.

Methods

The infection prevalence and intensity of An. stephensi mosquitoes that fed upon control or type 2 diabetic C57BL/6 db/db mice infected with either lethal Plasmodium berghei NK65 or non-lethal Plasmodium yoelii 17XNL murine malaria strains were determined. Daily parasitaemias were also recorded.

Results

A higher percentage of mosquitoes (87.5 vs 61.5 % for P. yoelii and 76.9 vs 50 % for P. berghei) became infected following blood feeding on Plasmodium-infected type 2 diabetic mice compared to mosquitoes that fed on infected control animals, despite no significant differences in circulating gametocyte levels.

Conclusions

These results suggest that type 2 diabetic mice infected with malaria are more efficient at infecting mosquitoes, raising the question of whether a similar synergy exists in humans.

Keywords

Type 2 diabetesMalaria Plasmodium yoelii Plasmodium berghei Mosquito Anopheles

Background

It is currently estimated that 22 million people are living with type 2 diabetes (T2D) on the African continent and this population is projected to double by 2030 [1]. Concurrently, there are over 250 million new malaria cases worldwide, the majority of which occur on the African continent. In contrast to developed countries, where the prevalence of T2D is greatest in individuals >60 years old, T2D in lesser developed countries is highly prevalent in individuals 40–60 years old [2], suggesting a durable epidemiological impact of T2D-associated increased malaria risk [3]. The rising prevalence of T2D in these regions can largely be ascribed to changes in lifestyle and urbanization, resulting in greater levels of obesity and physical inactivity [4, 5]. Published reports have shown that patients with T2D are 46 % more likely to be infected with Plasmodium falciparum [3]. Yet, the impact of T2D on malaria transmission remains unexamined.

Interestingly, Plasmodium infection improves glucose homeostasis in humans [6, 7], and in murine models of T2D it appears that glycosylphosphatidylinositols (GPIs) of the parasite are able to mimic the effects of endogenous insulin signalling [810]. Previous studies have examined the development of asexual stage Plasmodium in T2D mice and noted delayed development of parasitaemia [10, 11] and a correlation between obesity and increased resistance to cerebral malaria [11]. Therefore in a rodent model, T2D hosts with malaria may have altered duration and/or intensity of infection, possibly making them more efficient disease reservoirs. Although these studies clearly demonstrated that T2D and obesity can impact circulating levels of asexual parasites in mice, to date no published studies have examined the effects of T2D on malaria transmission to mosquitoes in any mammalian system. The evidence to suggest an effect of T2D on malaria transmission comes primarily from murine experiments, thus these experiments were conducted in similar models. This study provides the first evidence that a metabolic disorder can enhance transmission of malaria parasites to mosquitoes using a rodent model of T2D and malaria.

Methods

Mosquitoes

Anopheles stephensi (Indian strain) were reared and maintained at 27 °C and 80 % humidity. All mosquito rearing and feeding protocols were approved and in accordance with regulatory guidelines and standards set by the University of California Davis Institutional Animal Care and Use Committee. For transmission studies, 50 laboratory-reared, 3- to 5-day old, female mosquitoes were kept on water overnight and then allowed to feed for 15 min on anesthetized Plasmodium-infected animals prior to peak parasitaemia. Non-blood-fed mosquitoes were removed and after 10 days, midguts from mosquitoes were dissected into PBS and stained with 0.1 % mercurochrome for direct counting of Plasmodium oocysts.

Mice

All animal experiments were approved by the UC Davis Institutional Animal Care and Use Committee and were performed in accordance with institutional guidelines on animal welfare. Six week-old female C57BL/6J and C57BL/6J db/db (B6.BKS(D)-Lepr db /J) mice were purchased from the Jackson Laboratories (Bar Harbor, ME, USA). Female CD-1 mice were purchased from Harlan Laboratories (Haslett, MI, USA). All mice were maintained in standard cages and received standard rodent chow (PMI lab chow number 5001) and sterile drinking water ad libitum.

Parasites

Plasmodium yoelii yoelii 17XNL and Plasmodium berghei NK65 stocks were obtained from BEI Resources Malaria Research and Reference Reagent Resource (Manassas, VA, USA). Parasite stocks were made by passage in CD-1 mice. Mice were inoculated intraperitoneally with ~1 × 106 infected red blood cells (RBCs) in 0.1 ml of saline. Daily percentages of parasitaemia in mice were calculated by counting the number of infected RBCs and dividing this number by the total number of RBCs in thin blood films stained with Giemsa (Sigma-Aldrich). Gametocytaemia was determined by visually quantifying gametocyte stage parasites and dividing this number by the total number of infected RBCs.

Statistics

For mosquito transmission studies, data were analysed using Mann–Whitney test. Differences in prevalence of infection were determined by Chi square test. For parasitaemia and gametocytaemia, data were analysed by Student’s t test.

Results

Similar to previously published reports, T2D mice infected with lethal P. berghei had decreased parasitaemias compared to infected wild-type controls, but gametocytaemias were no different from controls, except at day 4 post-infection (Fig. 1a, b). However, mosquitoes that fed upon P. berghei-infected T2D mice at day 5 post-infection had more than ten times the mean number of oocysts per positive midgut (Fig. 1c) compared to mosquitoes fed on infected wild-type mice. Further, nearly 60 % more mosquitoes were infected with at least one oocyst (Fig. 1d) after feeding on infected T2D mice compared to wild-type mice. In contrast, T2D mice infected with non-lethal P. yoelii parasites had significantly higher parasitaemias at day 8 compared to wild-type controls (Fig. 1e), but like P. berghei-infected mice, showed no significant differences in gametocytaemias (Fig. 1f). Interestingly, mosquitoes that fed upon P. yoelii-infected T2D and wild-type mice showed no differences in infection intensity (Fig. 1g). As with P. berghei, however, significantly more mosquitoes were infected with at least one oocyst following feeding on P. yoelii-infected T2D mice compared to infected wild-type mice (Fig. 1h). Thus, enhanced transmission was observed from T2D mice infected with lethal and non-lethal strains of malaria parasites.
Fig. 1

Parasitaemias, gametocytaemias and parasite transmission from wild-type (WT) and type 2 diabetic (T2D) C57BL/6 mice infected with malaria. a, e Parasitaemias and b, f gametocytaemias (mean ± SEM) were determined by visual counts from Giemsa-stained slides prepared from tail bleeds. n = 4–6, *p ≤ 0.05). c, d, g, h Prior to peak parasitaemia (day 5 for Plasmodium berghei and day 8 for Plasmodium yoelii yoelii 17XNL), mice were anesthetized and 50 mosquitoes/mouse were allowed to feed for 15 min. Mosquitoes were maintained on 10 % sucrose for 10 days at which point midguts were dissected and oocysts counted. n = 30–70 mosquitoes, *p ≤ 0.05

Discussion

These are the first data to show that T2D enhances the transmission of malaria parasites to a mosquito vector in a rodent model. In these studies, P. berghei NK65 were used as model for lethal cerebral malaria that more commonly affects children, and P. yoelii 17XNL, a model for non-lethal infection that is more typical of disease in adults. Increased transmission from T2D mice was observed, using different strains of murine malaria parasites with very different disease pathologies. Interestingly, no differences in infection intensity where observed in mosquitoes that fed upon P. yoelii-infected T2D and wild-type mice (Fig. 1g). This finding suggests that the factors that affect gametocyte development in the mosquito in a non-lethal P. yoelii infection are different than in a lethal P. berghei infection. Further studies are required to elucidate what these factors are and how they impact gametocyte development in the mosquito.

Plasmodium gametocytogenesis is defined by a succession of developmental stages, of which only mature male and female gametocytes are infectious to mosquitoes. Mature P. yoelii gametocytes sequester primarily in sub-dermal capillaries of the skin in mice, which provides protection from splenic clearance and promotes ingestion by mosquitoes during blood feeding [12]. Hosts with no detectable or sub-microscopic gametocytaemia retain the ability to infect mosquitoes, suggesting that significant numbers of mature gametocytes sequester in the skin [1215]. As in data shown here, the association between circulating gametocyte densities in the mammalian host and infectivity to mosquitoes is not always linear [16]. Notably, altered parasite sequestration that is not correlated with peripheral gametocytaemia could contribute to enhanced transmission from T2D mice relative to wild-type mice. Therefore, future studies will examine if specific alterations in parasite sequestration occur in diabetic animals.

As the population of adults suffering from T2D continues to increase in malaria-endemic regions, these findings suggest that this co-morbidity could impact treatment and control efforts for both diseases in these regions. Indeed, health systems in low-resource countries have largely focused on acute rather than chronic care, which coupled with limited care access and delayed diagnosis of T2D contributes to more severe T2D disease and complications at the time of diagnosis [1]. Despite predictions that malaria-endemic African and Asian nations will face steeply rising incidences of T2D, few published reports have examined this co-morbidity. Indeed, beyond the activity of Plasmodium GPIs as insulin mimetics [810], little is known of how malaria might alter the pathology of T2D and how treatment of T2D might impact malaria infection and, more specifically, transmission. Thus, further investigations of T2D and malaria co-morbidity could inform future health interventions for these diseases.

Conclusion

Type 2 diabetic mice infected with either P. yoelii or P. berghei resulted in a higher prevalence of infected An. stephensi when compared to wild-type controls. These mice also had significantly lower parasitaemias but no significant differences in circulating gametocyte levels. These data suggest that this co-morbidity in humans could significantly alter the infectious reservoir and transmission of malaria and should therefore be examined more closely.

Abbreviations

GPIs: 

glycosylphosphatidylinositols

T2D: 

type 2 diabetes

P. berghei

Plasmodium berghei

P. yoelii yoelii

Plasmodium yoelii yoelii

RBC: 

red blood cells

Declarations

Authors’ contributions

NP designed experiments, acquired and analysed the data, and wrote the manuscript. KWC assisted in the design and acquisition of data. SL helped design experiments, interpret the data, and edited the manuscript. All authors read and approved the final manuscript.

Acknowledgements

We thank Caitlin Tiffany (University of California, Davis, Davis, CA, USA) for her technical support. Funding for these studies was provided by the University of California, Davis.

Competing interests

The authors declare that they have no competing interests.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Department of Medical Microbiology and Immunology, School of Medicine, University of California
(2)
Department of Biological Sciences, California State University East Bay

References

  1. International Diabetes Federation. IDF diabetes atlas. 6th ed. Belgium: Brussels; 2013.Google Scholar
  2. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet. 2006;367:1747–57.View ArticlePubMedGoogle Scholar
  3. Danquah I, Bedu-Addo G, Mockenhaupt FP. Type 2 diabetes mellitus and increased risk for malaria infection. Emerg Infect Dis. 2010;16:1601–4.View ArticlePubMedPubMed CentralGoogle Scholar
  4. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27:1047–53.View ArticlePubMedGoogle Scholar
  5. Brancati FL, Kao WH, Folsom AR, Watson RL, Szklo M. Incident type 2 diabetes mellitus in African American and white adults: the atherosclerosis risk in communities study. JAMA. 2000;283:2253–9.View ArticlePubMedGoogle Scholar
  6. Darby SM, Miller ML, Allen RO, LeBeau M. A mass spectrometric method for quantitation of intact insulin in blood samples. J Anal Toxicol. 2001;25:8–14.View ArticlePubMedGoogle Scholar
  7. White NJ, Warrell DA, Chanthavanich P, Looareesuwan S, Warrell MJ, Krishna S, et al. Severe hypoglycemia and hyperinsulinemia in falciparum malaria. N Engl J Med. 1983;309:61–6.View ArticlePubMedGoogle Scholar
  8. Elased KM, Gumaa KA, de Souza JB, Playfair JH, Rademacher TW. Improvement of glucose homeostasis in obese diabetic db/db mice given Plasmodium yoelii glycosylphosphatidylinositols. Metabolism. 2004;53:1048–53.View ArticlePubMedGoogle Scholar
  9. Elased KM, Gumaa KA, de Souza JB, Rahmoune H, Playfair JH, Rademacher TW. Reversal of type 2 diabetes in mice by products of malaria parasites. II. Role of inositol phosphoglycans (IPGs). Mol Genet Metab. 2001;73:248–58.View ArticlePubMedGoogle Scholar
  10. Elased K, De Souza JB, Playfair JH. Blood-stage malaria infection in diabetic mice. Clin Exp Immunol. 1995;99:440–4.View ArticlePubMedPubMed CentralGoogle Scholar
  11. Robert V, Bourgouin C, Depoix D, Thouvenot C, Lombard MN, Grellier P. Malaria and obesity: obese mice are resistant to cerebral malaria. Malar J. 2008;7:81.View ArticlePubMedPubMed CentralGoogle Scholar
  12. Gautret P, Miltgen F, Chabaud AG, Landau I. Synchronized Plasmodium yoelii yoelii: pattern of gametocyte production, sequestration and infectivity. Parassitologia. 1996;38:575–7.PubMedGoogle Scholar
  13. Drakeley C, Sutherland C, Bousema JT, Sauerwein RW, Targett GA. The epidemiology of Plasmodium falciparum gametocytes: weapons of mass dispersion. Trends Parasitol. 2006;22:424–30.View ArticlePubMedGoogle Scholar
  14. Gautret P, Miltgen F, Gantier JC, Chabaud AG, Landau I. Enhanced gametocyte formation by Plasmodium chabaudi in immature erythrocytes: pattern of production, sequestration, and infectivity to mosquitoes. J Parasitol. 1996;82:900–6.View ArticlePubMedGoogle Scholar
  15. Tiburcio M, Sauerwein R, Lavazec C, Alano P. Erythrocyte remodeling by Plasmodium falciparum gametocytes in the human host interplay. Trends Parasitol. 2015;31:270–8.View ArticlePubMedGoogle Scholar
  16. Churcher TS, Bousema T, Walker M, Drakeley C, Schneider P, Ouedraogo AL, et al. Predicting mosquito infection from Plasmodium falciparum gametocyte density and estimating the reservoir of infection. Elife. 2013;2:e00626.View ArticlePubMedPubMed CentralGoogle Scholar

Copyright

© Pakpour et al. 2016

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Advertisement